Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects
Abstract
BACKGROUND: Results of recent studies show that the risk for venous thrombosis is highest during initial oral contraceptive use. This suggests a subgroup of females who are at immediate risk of thrombosis when exposed to oral contraceptives. OBJECTIVE: To determine whether women with inherited clotting defects who use oral contraceptives develop venous thrombosis at an earlier stage than do those without inherited clotting defects. METHODS: Analysis of the data from the Leiden Thrombophilia Study, a population-based case-control study with data on duration of oral contraceptive use and recently detected genetic coagulation disorders. Patients had a first episode of objectively proven deep vein thrombosis. Patients and controls were considered thrombophilic when they had protein C deficiency, protein S deficiency, antithrombin deficiency, factor V Leiden mutation, or prothrombin 20210 A mutation. RESULTS: Risk of developing deep vein thrombosis was greatest in the first 6 months and the first year of oral contraceptive use. Compared with prolonged use, the risk of developing deep vein thrombosis was 3-fold higher in the first 6 months of use (95% confidence interval [CI], 0.6-14.8) and 2-fold higher in the first year of use (95% CI, 0.6-6.1). Patients who developed venous thrombosis in the early periods of use were more often thrombophilic. Among women with thrombophilia, the risk of developing deep vein thrombosis during the first 6 months of oral contraceptive use (compared with prolonged use) was increased 19-fold (95% CI, 1.9-175.7), and in the first year of use, it was increased 11-fold (95% CI, 2.1-57.3). CONCLUSIONS: Women with inherited clotting defects who use oral contraceptives develop venous thrombosis not only more often but also sooner than do those without inherited clotting defects. Venous thrombosis in the first period of oral contraceptive use might indicate the presence of an inherited clotting defect.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The most common clinical presentation of estrogen-related thrombosis is venous thromboembolism of the deep veins of the legs or pulmonary vessels, usually within the first few months of use.
“The most common clinical presentation of estrogen-related thrombosis is venous thromboembolism (VTE) of the deep veins of the legs or pulmonary vessels, usually within the first few months of use.”
From Estrogen and thrombosis: a bench to bedside review (2020) · cites this paper as [101]
Data from the population-based case-control Leiden Thrombophilia Study showed that the risk of developing VTE was greatest in the first 6 months of CHC use.
“Data from the population-based case-control Leiden Thrombophilia Study showed that the risk of developing VTE was greatest in the first 6 months of CHC use.”
From Estrogen and thrombosis: a bench to bedside review (2020) · cites this paper as [101]
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,769 · see citing works
Self-citationPoort, S., Rosendaal, F. R., Reitsma, P. H., & Bertina, R. M. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,064 · see citing works
Self-citationKoster, T., Vandenbroucke, J. P., Rosendaal, F. R., de Ronde, H., Briët, E., & Bertina, R. M. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,236 · see citing works
Self-citationVandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063 · see citing works
Self-citationRosendaal, F. R., Koster, T., Vandenbroucke, J. P., & Reitsma, P. H. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 999 · see citing works
Self-citationSpitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590 · see citing works
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576 · see citing works
Self-citationInvestigation of relation between use of oral contraceptives and thromboembolic disease.
Vessey, M. P., & Doll, R. (1968) · BMJ · doi:10.1136/bmj.2.5599.199 · Cited by 471 · see citing works
Vessey, M. P., & Doll, R. (1969) · BMJ · doi:10.1136/bmj.2.5658.651 · Cited by 403 · see citing works
Koster, T., Rosendaal, F. R., Briët, E., van der Meer, F. J. M., Colly, L. P., Trienekens, P., Poort, S., Reitsma, P. H., & Vandenbroucke, J. P. (1995) · Blood · doi:10.1182/blood.v85.10.2756.bloodjournal85102756 · Cited by 362 · see citing works
Self-citationTHROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12
Sartwell, P. E., Masi, A. T., Arthes, F. G., Greene, G. R., & Smith, H. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121082 · Cited by 341 · see citing works
Rosing, J., Tans, G., Nicolaes, G. A. F., Thomassen, M. C. L. G. D., Van Oerle, R., Van DerPloeg, P. M. E. N., Heijnen, P., Hamulyak, K., & Hemker, H. C. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.192707.x · Cited by 325 · see citing works
Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke, J. P., van der Meer, F. J. M., Helmerhorst, F. M., & Rosendaal, F. R. (1996) · BMJ · doi:10.1136/bmj.313.7065.1127 · Cited by 202 · see citing works
Self-citationFirst-time use of newer oral contraceptives and the risk of venous thromboembolism
Suissa, S., Blais, L., Spitzer, W. O., Cusson, J. R., Lewis, M., & Heinemann, L. A. J. (1997) · Contraception · doi:10.1016/s0010-7824(97)00119-4 · Cited by 192 · see citing works
Bloemenkamp, K. W. M., Rosendaal, F. R., Buller, H. R., Helmerhorst, F. M., Colly, L. P., & Vandenbroucke, J. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.65 · Cited by 141 · see citing works
Self-citationPabinger, I., & Schneider, B. (1994) · PubMed · Cited by 129 · see citing works
Resistance to activated protein C in healthy women taking oral contraceptives
Olivieri, O., Friso, S., Manzato, F., Guella, A., Bernardi, F., Lunghi, B., Girelli, D., Azzini, M., Brocco, G., Russo, C. A., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05323.x · Cited by 128 · see citing works
Venous thromboembolism in relation to oral contraceptive use.
Helmrich, S. P., Rosenberg, L. A., Kaufman, D. W., Strom, B. L., & Shapiro, S. (1987) · PubMed · Cited by 111 · see citing works
Sensitivity to Activated Protein C; Influence of Oral Contraceptives and Sex
Henkens, C. M. A., BOM, V. J. J., Seinen, A. J., & van der Meer, J. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653788 · Cited by 110 · see citing works
Newer Oral Contraceptives and the Risk of Venous Thromboembolism
Walker, A. M. (1998) · Contraception · doi:10.1016/s0010-7824(98)00014-6 · Cited by 98 · see citing works
FAMILY HISTORY AND INHERITED THROMBOPHILIA
Briët, E., van der Meer, F. J., Rosendaal, F. R., Houwing‐Duistermaat, J. J., & van Houwelingen, H. C. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08400.x · Cited by 55 · see citing works
Self-citationDj, G., Hw, O., & Levy, M. F. (1973) · PubMed · Cited by 50 · see citing works
Resistance to activated protein C is reduced in women using oral contraceptives
Østerud, B., Robertsen, R., Åsvang, G. B., & Thijssen, F. (1994) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199410000-00030 · Cited by 38 · see citing works
Farley, T., Meirik, O., Marmot, M. G., Cl, C., & Poulter, N. R. (1998) · Contraception · doi:10.1016/s0010-7824(97)00209-6 · Cited by 32 · see citing works
Thrombotic risk factors and oral contraception.
Bokarewa, M. I., Falk, G., Sten-Linder, M., Egberg, N., Blombäck, M., & Bremme, K. A. (1995) · PubMed · Cited by 17 · see citing works
Henkens, C., Vandermeer, J., Pelsma, P., Geerards, S., Bom, V., & van der Schaaf, W. (1995) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456 · see citing works
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406 · see citing works
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 620 · see citing works
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 580 · see citing works
Self-citationWu, O., Robertson, L., Twaddle, S., Lowe, G. D. O., Clark, P., Greaves, M., Walker, I. D., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489 · see citing works
Murayama, K. M. (2007) · Cited by 477 · see citing works
Kujovich, J. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 422 · see citing works
Female Hormones and Thrombosis
Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.102318 · Cited by 267 · see citing works
Self-citationEstrogen and thrombosis: a bench to bedside review
Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.008 · Cited by 261 · see citing works
Venous Thrombosis: The Role of Genes, Environment, and Behavior
Rosendaal, F. R. (2005) · Hematology · doi:10.1182/asheducation-2005.1.1 · Cited by 252 · see citing works
Self-citationCombination Estrogen–Progestin Oral Contraceptives
Petitti, D. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030751 · Cited by 241 · see citing works
Rezende, S. M., Simmonds, R. E., & Lane, D. A. (2003) · Blood · doi:10.1182/blood-2003-05-1551 · Cited by 223 · see citing works
Cerebral venous sinus thrombosis
Capecchi, M., Abbattista, M., & Martinelli, I. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14210 · Cited by 222 · see citing works
Mechanisms of estrogen-induced venous thromboembolism
Tchaikovski, S. N., & Rosing, J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.045 · Cited by 219 · see citing works
Estrogens, progestogens and thrombosis
Rosendaal, F. R., Vlieg, A. V. H., Tanis, B. C., & Helmerhorst, F. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00264.x · Cited by 189 · see citing works
Self-citationOral Contraceptives and HRT Risk of Thrombosis
Gialeraki, A. E., Valsami, S. I., Pittaras, T., Panayiotakopoulos, G. D., & Politou, M. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616683802 · Cited by 169 · see citing works
Abdominal Dermolipectomies: Early Postoperative Complications and Long-Term Unfavorable Results
Chaouat, M., Levan, P., Lalanne, B., Buisson, T., Nicolau, P., & Mimoun, M. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200012000-00029 · Cited by 166 · see citing works
Combined hormonal contraception and the risk of venous thromboembolism: a guideline
Pfeifer, S., Butts, S., Dumesic, D. A., Fossum, G., Gracia, C., Barbera, A. L., Mersereau, J., Odem, R., Penzias, A. S., Pisarska, M. D., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.027 · Cited by 158 · see citing works
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis
Rosendaal, F. R., Vessey, M. P., Rumley, A., Daly, E., Woodward, M., Helmerhorst, F. M., & Lowe, G. D. O. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03356.x · Cited by 153 · see citing works
Self-citation(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003072 · Cited by 147 · see citing works
van Vlijmen, E. F. W., Wiewel‐Verschueren, S., Monster, T. B. M., & Meijer, K. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13349 · Cited by 136 · see citing works
Press, R. D., Bauer, K. A., Kujovich, J. L., & Heit, J. A. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1304-cuofvl · Cited by 134 · see citing works
Pharmacogenetics: potential for individualized drug therapy through genetics
Johnson, J. A. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.008 · Cited by 121 · see citing works
Liposuction as an Adjunct to a Full Abdominoplasty Revisited
Matarasso, A. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200010000-00035 · Cited by 114 · see citing works
Oral Contraceptives, Hormone Replacement Therapy and Thrombosis
Helmerhorst, F. M., Vandenbroucke, J. P., & Rosendaal, F. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616207 · Cited by 109 · see citing works
Self-citationPernod, G., Biron‐Andréani, C., Morange, P., Boehlen, F., Constans, J., Couturaud, F., Drouet, L. O., Jude, B., Lecompte, T., Gal, G. L., et al. (2009) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2009.02.005 · Cited by 104 · see citing works
Hormones and pregnancy: thromboembolic risks for women
Kujovich, J. L. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05041.x · Cited by 99 · see citing works
Oral Contraceptives and Venous Thromboembolism
Manzoli, L., Vito, C. D., Marzuillo, C., Boccia, A., & Villari, P. (2012) · Drug Safety · doi:10.2165/11598050-000000000-00000 · Cited by 93 · see citing works
van Vlijmen, E. F. W., Veeger, N. J. G. M., Middeldorp, S., Hamulyák, K., Prins, M. H., Buller, H. R., & Meijer, K. (2011) · Blood · doi:10.1182/blood-2011-03-345678 · Cited by 86 · see citing works
Clinical and Laboratory Management of the Prothrombin G20210A Mutation
McGlennen, R. C., & Key, N. S. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1319-calmot · Cited by 82 · see citing works
Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis
Wysokinska, E. M., Wysokiński, W. E., Brown, R. D., Karnicki, K., Gosk, I., Grill, D. E., & McBane, R. D. (2008) · Neurology · doi:10.1212/01.wnl.0000297195.97325.a8 · Cited by 80 · see citing works
Rosendaal, F. R. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0108-y · Cited by 79 · see citing works
Self-citationLaboratory Evaluation of Hypercoagulability With Venous or Arterial Thrombosis
Cott, E. M. V., Laposata, M., & Prins, M. H. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1281-leohwv · Cited by 74 · see citing works
A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism
Dicks, A. B., Moussallem, E., Stanbro, M. D., Walls, J., Gandhi, S. S., & Gray, B. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020362 · Cited by 79 · see citing works
Hennessy, S., Berlin, J. A., Kinman, J. L., Margolis, D. J., Marcus, S. M., & Strom, B. L. (2001) · Contraception · doi:10.1016/s0010-7824(01)00234-7 · Cited by 72 · see citing works
Cushman, M., Costantino, J. P., Bovill, E. G., Wickerham, D. L., Buckley, L. M., Roberts, J. D., & Krag, D. N. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03976.x · Cited by 68 · see citing works
Vandenbroucke, J., & Pearce, N. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv225 · Cited by 67 · see citing works
Self-citationMolecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity
Johnson, J. A., & Evans, W. E. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02354-7 · Cited by 65 · see citing works
Long-Cycle Treatment with Oral Contraceptives
Wiegratz, I., & Kühl, H. (2004) · Drugs · doi:10.2165/00003495-200464210-00006 · Cited by 65 · see citing works
Franchini, M., Veneri, D., Salvagno, G. L., Manzato, F., & Lippi, G. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600552678 · Cited by 63 · see citing works
Pros and cons of thrombophilia testing: cons
Machin, S. J. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00168.x · Cited by 62 · see citing works
Evidence-based indications for thrombophilia screening
Lindhoff-Last, & Luxembourg (2008) · VASA · doi:10.1024/0301-1526.37.1.19 · Cited by 57 · see citing works
Testing for thrombophilia: an evidence-based approach
Merriman, L., & Greaves, M. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.048090 · Cited by 57 · see citing works
Mohllajee, A. P., Curtis, K. M., Martins, S. L., & Peterson, H. B. (2005) · Contraception · doi:10.1016/j.contraception.2005.08.011 · Cited by 57 · see citing works
Oral Contraceptives and Venous Thromboembolism
Reid, R. L., Westhoff, C. L., Mansour, D., de Vries, C., Verhaeghe, J., Boschitsch, E., Gompel, A., Birkhäuser, M., Křepelka, P., Ďulíček, P., et al. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910791749425 · Cited by 56 · see citing works
Venous thromboembolism in women using hormonal contraceptives
Blanco-Molina, Á., Trujillo‐Santos, J., Tirado, R., Cañas, I., Riera, A., Valdés, M., Monréal, M., & for the RIETE Investigators (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0684 · Cited by 55 · see citing works
van Rooijen, M., Silveira, A. M. V., Hamsten, A., & Bremme, K. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00950-5 · Cited by 55 · see citing works
Lowe, G. D. O. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01400.x · Cited by 54 · see citing works
Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy
Mullins, E. S., Geer, R., Metcalf, M., Piccola, J., Lane, A., Conard, L. A. E., & Mullins, T. L. K. (2021) · PEDIATRICS · doi:10.1542/peds.2020-023549 · Cited by 54 · see citing works
Risk of venous thromboembolic disease in women
Romero, A., Alonso, C., Rincón, M., Medrano, J., Santos‐Lozano, J. M., Calderón, E. J., Marín, I., & González, M.-A. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.11.023 · Cited by 49 · see citing works
Acquired and Congenital Risk Factors associated with Cerebral Venous Sinus Thrombosis
McBane, R. D., Tafur, A. J., & Wysokiński, W. E. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.04.015 · Cited by 47 · see citing works
Ďulíček, P., Ivanova, E. Y., Košťál, M., Sadílek, P., Beránek, M., Зак, П., & Hirmerová, J. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617727857 · Cited by 47 · see citing works
The action of ovarian hormones in cardiovascular disease
Medina, R. A., Aranda, E., VERDUGO, C., Kato, S., & Owen, G. I. (2003) · Biological Research · doi:10.4067/s0716-97602003000300005 · Cited by 46 · see citing works
Gomes, M. P. V., & Deitcher, S. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1965 · Cited by 44 · see citing works
Epidemiology of the contraceptive pill and venous thromboembolism
Hannaford, P. C. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70009-3 · Cited by 45 · see citing works
Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study
Martinelli, I., Maino, A., Abbattista, M., Bucciarelli, P., Passamonti, S. M., Artoni, A., Gianniello, F., & Peyvandi, F. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.03.025 · Cited by 42 · see citing works
Tanis, B. C., Bloemenkamp, D. G. M., van den Bosch, M. A. A. J., Kemmeren, J. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04454.x · Cited by 39 · see citing works
Self-citationTherapy Insight: guidelines for selection of contraception in women with rheumatic diseases
Sammaritano, L. R. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0484 · Cited by 38 · see citing works
Hormone therapy and thromboembolic disease
Battaglioli, T., & Martinelli, I. (2007) · Current Opinion in Internal Medicine · doi:10.1097/moh.0b013e32825f5302 · Cited by 38 · see citing works
Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis
Saadatnia, M., & Tajmirriahi, M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00824.x · Cited by 35 · see citing works
Canadian Contraception Consensus
(2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30260-2 · Cited by 33 · see citing works
RETIRED: Oral Contraceptives and the Risk of Venous Thromboembolism: An Update
Reid, R. L., Leyland, N. A., Wolfman, W., Allaire, C., Awadalla, A., Best, C., Dunn, S., Lemyre, M., Marcoux, V., Ménard, C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34746-6 · Cited by 31 · see citing works
Thrombophilia: Clinical and Laboratory Assessment and Management
Heit, J. A. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10014-8 · Cited by 31 · see citing works
Wiegratz, I., Stahlberg, S., Manthey, T., Sänger, N., Mittmann, K., Lange, E., Mellinger, U., & Kühl, H. (2008) · Contraception · doi:10.1016/j.contraception.2008.06.015 · Cited by 30 · see citing works
Baratloo, A., Safari, S., Rouhipour, A., Hashemi, B., Rahmati, F., Motamedi, M., Forouzanfar, M., & Haroutunian, P. (2014) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v2i1.14 · Cited by 30 · see citing works
Oral contraception and thrombophilia
Blickstein, D., & Blickstein, I. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32821642e6 · Cited by 30 · see citing works
Venous thromboembolism in women taking hormonal contraceptives
Blanco-Molina, Á., & Monréal, M. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.175 · Cited by 32 · see citing works
Risk factors for thromboembolism in teens: when should I test?
Sass, A. E., & Neufeld, E. J. (2002) · Current Opinion in Pediatrics · doi:10.1097/00008480-200208000-00002 · Cited by 28 · see citing works
Thrombophilias and gynaecology
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., & Vandenbroucke, J. P. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(03)00015-4 · Cited by 27 · see citing works
Self-citationSardo, A. D. S. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s6954 · Cited by 26 · see citing works
Amiral, J., & Seghatchian, J. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.04.010 · Cited by 26 · see citing works
Naushad, S. M., Jamal, M. N. J., Angalena, R., Prasad, C. K., & Devi, A. R. R. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3280108e01 · Cited by 26 · see citing works
Rapid activation of haemostasis after hormonal emergency contraception
Silveira, A. M. V., Thomassen, S., Hansson, L., Rosing, J., Hamsten, A., Bremme, K., & van Rooijen, M. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-09-0540 · Cited by 26 · see citing works
Abdominal Dermolipectomies: Early Postoperative Complications and Long-Term Unfavorable Results
Chaouat, M., Levan, P., Lalanne, B., Buisson, T., Nicolau, P., & Mimoun, M. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200012000-00030 · Cited by 26 · see citing works
Cerebral Vein and Sinus Thrombosis in Isfahan-Iran: A Changing Profile
Saadatnia, M., Mousavi, S. A., Haghighi, S., & Aminorroaya, A. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003656 · Cited by 25 · see citing works
Clinical Presentation and Risk Factors of Venous Thromboembolic Disease
Alhassan, S., Pelinescu, A., Gandhi, V., Naddour, M., Singh, A. C., & Bihler, E. (2017) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000159 · Cited by 23 · see citing works
Carraro, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.059 · Cited by 23 · see citing works
Zöller, B., Ohlsson, H., Sundquist, J., & Sundquist, K. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0065-x · Cited by 22 · see citing works
Factor V Leiden associated with flap loss in microsurgical breast reconstruction
Khansa, I., Colakoğlu, S., Tomich, D., Nguyen, M.-D. T., & Lee, B. T. (2011) · Microsurgery · doi:10.1002/micr.20879 · Cited by 22 · see citing works
Laboratory thrombophilias and venous thromboembolism
Joffe, H. V., & Goldhaber, S. Z. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm426ra · Cited by 20 · see citing works
Thrombotic risk associated with gender-affirming hormone therapy
Mullins, T. L. K., & Mullins, E. S. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.05.015 · Cited by 19 · see citing works
Vernon, E., Hiedemann, B. G., & Bowie, B. H. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0318-x · Cited by 19 · see citing works
Thrombophilic screening in Turner syndrome.
Calcaterra, V., Gamba, G., Montani, N., Silvestri, A. D., Terulla, V., Lanati, G., & Larizza, D. (2011) · PubMed · doi:10.3275/7724 · Cited by 17 · see citing works
Egermayer, P., & Frampton, C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.484 · Cited by 17 · see citing works
Verhaeghe, J. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1676-x · Cited by 16 · see citing works
Gartner, V., Weber, M., & Eichinger, S. (2008) · Contraception · doi:10.1016/j.contraception.2008.06.008 · Cited by 16 · see citing works
Heit, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00014-2 · Cited by 16 · see citing works
Hypercoagulability and venous thromboembolism: a review.
Mazza, J. J. (2004) · PubMed · Cited by 15 · see citing works
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
Reda, S., Morimont, L., Douxfils, J., & Rühl, H. (2020) · Hämostaseologie · doi:10.1055/a-1153-5824 · Cited by 17 · see citing works
Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis
Martinelli, I., Battaglioli, T., & Mannucci, P. M. (2003) · Pharmacogenetics · doi:10.1097/00008571-200310000-00002 · Cited by 15 · see citing works
Ďulíček, P., Maly, J., Pecka, M., Beránek, M., Čermáková, E., & Malý, R. (2008) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029608325544 · Cited by 14 · see citing works
Andreassi, M. G., Botto, N., & Maffei, S. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.103 · Cited by 14 · see citing works
Dayan, N., Holcroft, C., & Tagalakis, V. (2011) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610391652 · Cited by 14 · see citing works
Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age
Momot, A. P., Nikolaeva, M. G., Yasafova, N. N., Зайнулина, М. С., Momot, K. A., & Taranenko, I. A. (2019) · Journal of Blood Medicine · doi:10.2147/jbm.s212759 · Cited by 14 · see citing works
Mishell, J., & Shoupe, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-20185-6 · Cited by 14 · see citing works
Communicating benefit and risk
Baglin, T. P. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07709.x · Cited by 13 · see citing works
Use of hormones and risk of venous thromboembolism
de Barros, V. I. P. V. L., de Oliveira, A. L. M. L., Nascimento, D. J., Zlotnik, E., Teruchkin, M. M., Marques, M. A., & Margarido, P. F. R. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024fps02 · Cited by 12 · see citing works
Hasegawa, S., Matsui, T., Hane, Y., Abe, J., Hatahira, H., Motooka, Y., Sasaoka, S., Fukuda, A., Naganuma, M., Hirade, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182045 · Cited by 12 · see citing works
Update on the Cardiovascular Risks of Hormone Replacement Therapy
Lowe, G. D. O. (2006) · Women s Health · doi:10.2217/17455057.3.1.87 · Cited by 12 · see citing works
Acute Renal Vein Thrombosis, Oral Contraceptive Use, and Hyperhomocysteinemia
Chan, H. H. W., Douketis, J. D., & Nowaczyk, M. J. M. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.2.212 · Cited by 12 · see citing works
- Authors
- Bloemenkamp, K. W. M., Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P.
- Affiliations
- Leiden University Medical Center (NL)
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-01-10
- Volume
- 160
- Issue
- 1
- Pages
- 49
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2163417915
- Cited by
- 213
- References
- 27
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 10 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 5
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- venous thrombosis, deep vein thrombosis, oral contraceptives, thrombophilia, duration of contraceptive use, protein C deficiency, protein S deficiency, antithrombin deficiency, factor V Leiden, prothrombin G20210A
- MeSH terms
- Adolescent, Adult, Blood Coagulation Disorders, Contraceptives, Oral, Female, Humans, Middle Aged, Risk, Risk Factors, Time Factors, Case-Control Studies, Venous Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review